Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US industry keeps keen eye on drug bill's device content

This article was originally published in Clinica

Executive Summary

Several items on the device industry's Medicare agenda are well on their way to adoption. They were included in both of the Medicare Prescription Drug Bills that passed both the US House and the US Senate last week, meaning they are all but certain to be incorporated in the final bill to be ironed out in a House and Senate conference committee which is likely to meet later this month.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel